Patient Leaflet Updated 19-Mar-2024 | Thame Laboratories
Ondansetron 4mg/5ml Syrup
Ondansetron 4mg/5ml Syrup
The name of your medicine is Ondansetron 4mg/5ml Syrup but it will be referred as Ondansetron throughout this leaflet.
1. What Ondansetron is and what it is used for
2. What you need to know before you take Ondansetron
3. How to take Ondansetron
4. Possible side effects
5. How to store Ondansetron
6. Contents of the pack and other information
Ondansetron contains the active substance ondansetron hydrochloride dihydrate. This belongs to a group of medicines called anti-emetics.
Ondansetron is used for:
Ask your doctor, nurse or pharmacist if you would like any further explanation about these uses.
Ondansetron should start to work within one or two hours of taking a dose. You must talk to a doctor if you do not feel better or if you feel worse.
If you are not sure, talk to your doctor, nurse or pharmacist before taking Ondansetron.
Talk to your doctor or pharmacist before taking Ondansetron if:
If you are not sure if any of the above apply to you, talk to your doctor, nurse or pharmacist before taking Ondansetron.
Do not give this medicine to children under 6 months of age
Tell your doctor, nurse or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines obtained without a prescription and herbal medicines. This is because Ondansetron can affect the way some medicines work. Also some medicines can affect the way Ondansetron works.
In particular, tell your doctor, nurse or pharmacist if you are taking any of the following medicines:
If you are not sure if any of the above applies to you, talk to your doctor, nurse or pharmacist before having Ondansetron.
Only use Ondansetron during the first trimester of pregnancy after discussion with your doctor of the potential benefits and risks to you and your unborn baby of the different treatment options. This is because Ondansetron can slightly increase the risk of a baby being born with cleft lip and/or cleft palate (openings or splits in the upper lip and/or the roof of the mouth).
If you are already pregnant, think you might be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking Ondansetron.
If you are a woman of childbearing potential you may be advised to use effective contraception.
Do not breast-feed if you are taking Ondansetron. This is because small amounts pass into the mother's milk. Ask your doctor or midwife for advice.
It is not expected that Ondansetron will affect your ability to drive; however, if any of the side effects (listed section 4) affect you (e.g. dizziness, blurred vision) caution is advisable. Do not drive or operate machines if you are feeling unwell.
Sorbitol (E420): This medicine contains 2100mg sorbitol in each 5ml dose which is equivalent to 420mg/ml. Sorbitol is a source of fructose. If your doctor has told you that you (or your child) have an intolerance to some sugars or if you have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disorder in which a person cannot break down fructose, talk to your doctor before you (or your child) take or receive this medicine. Sorbitol may cause gastrointestinal discomfort and mild laxative effect.
Sodium benzoate (E211): This medicine contains 6mg sodium benzoate in each 5ml dose which is equivalent to 1.2mg/ml.
Propylene glycol (E1520): This medicine contains 14.1mg/5ml propylene glycol in each 5ml dose which is equivalent to 2.8mg/ml.
Sodium: This medicine contains less than 1 mmol sodium (23 mg) per 5ml dose, that is to say essentially 'sodium-free'.
Always take this medicine exactly as your doctor has told you. Check with your doctor, nurse or pharmacist if you are not sure.
The dose you have been prescribed will depend on the treatment you are having.
Do not mix Ondansetron with anything (not even water) before swallowing it.
The recommended dose is:
To prevent nausea and vomiting from chemotherapy or radiotherapy
Adults:
On the day of chemotherapy or radiotherapy:
On the following days:
If your chemotherapy or radiotherapy is likely to cause severe nausea and vomiting, you may be given more than the usual dose of Ondansetron. Your doctor will decide this.
Children and Adolescents (6 months to 17 years):
To prevent nausea and vomiting from chemotherapy only:
The doctor will decide the dose depending on the child’s size (body surface area) or weight.
Infants under 6 months of age:
Ondansetron is not recommended in infants under 6 months of age for the prevention of nausea and vomiting from chemotherapy.
To prevent nausea and vomiting after an operation
Adults:
The usual adult dose is 16mg (four 5 ml spoonfuls, large end of spoon supplied in pack) given an hour before your operation.
Children and Adolescents (aged 1 month to 17 years):
Children aged 2 years and over
It is recommended that Ondansetron is given as an injection.
Children aged under 2 years
There is little information on the correct dose of Ondansetron for the treatment of nausea & vomiting after an operation in children under 2 years of age. The doctor will decide the correct dose.
The total daily dose should not be more than 8mg (two 5 ml spoonfuls, large end of spoon supplied in pack). If you have blood tests to check how your liver is working, this medicine may affect the results.
If you continue to feel sick, tell your doctor or nurse.
Double-ended Spoon
If you or your child take more Ondansetron than you should, talk to a doctor or go to a hospital straight away. Take the medicine pack with you.
If you forget a dose and feel sick or vomit:
If you forget a dose but do not feel sick:
If you have any further questions on the use of this medicine, ask your doctor, nurse or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
These reactions are rare in people taking Ondansetron. If you have an allergic reaction, STOP taking it and see a doctor straight away. The signs may include:
Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Very rare (may affect up to 1 in 10,000 people)
Frequency unknown
Myocardial ischemia
Signs include:
If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in this leaflet.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
The active substance is ondansetron.
Each 5ml syrup contains 4mg ondansetron (as ondansetron hydrochloride dihydrate).
The other ingredients are citric acid monohydrate (E330), sodium citrate (E331), sorbitol, liquid (non crystallising) (E420), sodium benzoate (E211), strawberry flavour (contains propylene glycol (E1520)) and purified water.
Ondansetron is a clear, colourless syrup with a strawberry flavour. It is supplied in type III amber colour glass bottle with HDPE, EPE wadded, tamper evident, child resistant screw on white plastic polypropylene cap.
The pack also contains a plastic double ended spoon with the smaller end measuring 2.5ml and the larger end measuring 5ml.
Ondansetron is supplied in bottles containing 50ml, 100ml and 300ml syrup.
Not all pack sizes may be marketed.
POM
This medicine is authorised in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names:
IE, UK (NI): Ondansetron 4mg/5ml Syrup NL: Ondansetron 4 mg/5 ml Focus Care, Stroop
This leaflet was last revised in 10/2023.
PIL/UK/MFG101/03/PHA/v1
Unit 4, Bradfield Road, Ruislip, Middlesex, HA4 0NU
0330 1359 422
+44 (0)208 515 3700
http://www.thamelabs.co.uk
+44 (0)208 515 3700
+44 (0)208 515 3700